Literature DB >> 9771753

HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy.

E H Corder1, K Robertson, L Lannfelt, N Bogdanovic, G Eggertsen, J Wilkins, C Hall.   

Abstract

HIV produces a chronic viral infection of the central nervous system that elicits chronic glial activation and overexpression of glial cytokines that are also implicated in Alzheimer disease (AD) pathogenesis. A genetic risk factor for AD is the E4 isoform for apolipoprotein E (APOE). Here we compare the frequency of neurologic symptoms for subjects with and without the E4 isoform (E4(+)and E4(-), respectively) in an HIV cohort. Compared with E4(-) subjects, twice as many E4(+) subjects were demented (30% compared with 15%) or had peripheral neuropathy (70% compared with 39%) at least once, and they had threefold more symptomatic examinations (13% compared with 3% and 42% compared with 14%, respectively)(P < 0.0001). Thus, neurologic symptoms for HIV-infection and AD are linked through an etiologic risk factor. Long-term survivors of HIV infection with E4 may be at high risk for AD; conversely, gene-viral interactions may speed AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771753     DOI: 10.1038/2677

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  88 in total

1.  Sandwich ELISA for the measurement of Apo-E4 levels in serum and the estimation of the allelic status of Apo-E4 isoforms.

Authors:  Y Uchida; S Ito; N Nukina
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Association of HSV1 and apolipoprotein E-varepsilon4 in Alzheimer's disease.

Authors:  R F Itzhaki; C B Dobson; W R Lin; M A Wozniak
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

Review 3.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

4.  Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimer's amyloid precursor protein signalling.

Authors:  Tarek Kashour; Teralee Burton; Alexander Dibrov; Francis M Amara
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

5.  Alzheimer's disease and herpes.

Authors:  Ruth F Itzhaki; Curtis B Dobson
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

Review 6.  Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility.

Authors:  Megan K Patrick; James B Johnston; Christopher Power
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Depressed neurofilament expression associates with apolipoprotein E3/E4 genotype in maturing human fetal neurons exposed to HIV-1.

Authors:  Ricardo Martinez; Wu Chunjing; Rebeca Geffin; Micheline McCarthy
Journal:  J Neurovirol       Date:  2012-08       Impact factor: 2.643

8.  Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults.

Authors:  Andrew J Levine; Susan Service; Eric N Miller; Sandra M Reynolds; Elyse J Singer; Paul Shapshak; Eileen M Martin; Ned Sacktor; James T Becker; Lisa P Jacobson; Paul Thompson; Nelson Freimer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-24       Impact factor: 3.568

Review 9.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

10.  Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism.

Authors:  Jari H Stengård; Andrew G Clark; Kenneth M Weiss; Sharon Kardia; Deborah A Nickerson; Veikko Salomaa; Christian Ehnholm; Eric Boerwinkle; Charles F Sing
Journal:  Am J Hum Genet       Date:  2002-08-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.